Pulmonary Artery Denervation for Treatment of Patients With Pulmonary Hypertension Secondary to Heart Failure With Reduced Ejection Fraction: a Safety and Proof-of-principle Cohort Study
Conditions: To Analyze the Safety and Efficacy of PADN for Pulmonary Hypertension Secondary to HFrEF Interventions: Device: PADN Sponsors: Shaoliang Chen, MD Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Heart | Heart Failure | Hypertension | Pulmonary Hypertension | Research | Study